Your browser doesn't support javascript.
loading
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
Siddiqui, Maria; Konoplev, Sergej; Issa, Ghayas; Kantarjian, Hagop; Daver, Naval; Ravandi, Farhad; Kadia, Tapan; Tang, Guilin; Wang, Sa A; Thakral, Beenu; Medeiros, L Jeffrey; Pozdnyakova, Olga; Pierce, Sherry; Montalban-Bravo, Guillermo; Chien, Kelly; Hammond, Danielle; Sasaki, Koji; Garcia-Manero, Guillermo; Hasserjian, Robert P.
Afiliação
  • Siddiqui M; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Konoplev S; Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Issa G; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver N; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia T; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Tang G; Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang SA; Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Thakral B; Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Medeiros LJ; Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Pierce S; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Montalban-Bravo G; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Chien K; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Hammond D; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Sasaki K; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Garcia-Manero G; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Am J Hematol ; 98(4): E91-E94, 2023 04.
Article em En | MEDLINE | ID: mdl-36661399
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Síndromes Mielodisplásicas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Síndromes Mielodisplásicas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos